Enterovirus infection of neuronal cells post-Rituximab.
Kiani-Alikhan
Sorena
S
Skoulidis
Ferdinandos
F
Barroso
Ana
A
Nuovo
Gerard
G
Ushiro-Lumb
Ines
I
Breuer
Judith
J
Lister
Andrew
A
Mattes
Frank
F
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002524:Cerebellar Ataxia / Q000139:chemically induced / Q000821:virology; D004769:Enterovirus Infections / Q000139:chemically induced*; D017809:Fatal Outcome; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008297:Male; D008590:Meningoencephalitis / Q000139:chemically induced* / Q000821:virology; D008875:Middle Aged; D009474:Neurons / Q000821:virology*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab